The blood sugar and metabolic health market is on the rise as demand for blood sugar support grows.
The blood sugar and metabolic health market is continuing to expand, with supplement brands and retailers taking a more proactive approach to meet consumer demand for preventive care. Emerging research is demonstrating links between blood sugar and other aspects of human health like the gut microbiome, underscoring the importance of blood sugar management for consumers. The rise of GLP-1 drugs is also bringing blood sugar management to the forefront of consumers’ minds; meanwhile, emerging studies are demonstrating that nutraceutical ingredients can and do influence blood sugar in positive ways. Here are some of the major trends driving the blood sugar supplements market.
Blood Sugar Supplements Market Rapidly Expands
The blood sugar and metabolic health supplements market is undergoing explosive growth. James Roza, chief scientific officer of ingredient supplier Layn Natural Ingredients in Irvine, CA, explained that this market is rapidly expanding due to increased awareness of the importance of maintaining healthy glucose levels. He credited Ozempic and other GLP-1 drugs as the catalyst for growing interest in metabolic health, explaining that GLP-1 agonists were originally researched primarily for their use in maintaining healthy HA1C levels.
Meanwhile, Ingredients by Nature Commercial Lead Doug Lynch in Montclair, CA, noted that the definition of metabolic health has evolved, both for consumers and retailers. Blood sugar support, he said, is no longer a single-condition discussion; it is part of a broader metabolic framework that includes lipid balance, inflammatory tone, hormonal signalling and long-term healthy aging.
“Retailers are seeing customers who are increasingly educated about fasting glucose, triglycerides, insulin sensitivity and GLP-1s,” Lynch noted. “This shift reflects a deeper awareness that metabolic function underpins energy, cardiovascular health and body composition.”
Carl Germano, CNS, CDN, vice president of Verdant Nature and a consultant to Bluebonnet Nutrition in Sugar Land, TX, said that obesity rates, diabetes prevalence and consumer demand for natural alternatives to pharmaceuticals are all contributing to the rise of blood sugar and metabolic health supplements.
“Projections indicate strong expansion through 2036, with key segments like herbal extracts leading due to their perceived efficacy and safety,” Germano said. “Diabetes management supplements are valued at about $7.5-$8.4 billion in 2026, according to Grand View Research, and are forecasted to reach up to $17.7 billion by 2036. Related metabolic segments, such as weight management supplements, are projected to grow as well. North America dominates currently, with Asia-Pacific as the fastest-growing region.”
Germano noted that the single largest growth driver for these supplements is the increasing global incidence of diabetes. Furthermore, he explained, interest in preventive health and e-commerce expansion have also driven growth.
Other factors are also contributing to the growth of blood sugar management supplements. Loick Fenaux, vice president of the Americas for ingredient supplier Phynova in the United Kingdom, noted that over a billion people worldwide are in prediabetic states, and insulin resistance is becoming increasingly common even among younger populations. As a result, consumers are proactively seeking tools to help support healthy insulin sensitivity and metabolism.
This consumer enthusiasm for blood sugar supplements is being felt at the retailer level. Alina Hornfeldt, co-owner of supplement retailer Mastel’s Health Foods in St. Paul, MN, noted that she’s seeing strong and steady demand for blood sugar support supplements. Furthermore, she noted, this category feels more proactive than ever before. Blood sugar support used to be mostly reactive, with consumers coming in for supplements after a diagnosis. Now, Hornfeldt said, consumers with borderline labs are coming to Mastel’s for blood sugar and metabolic health supplements.
Travis Lemon, owner/operator of supplement retailer Tulsi at the Market in Huntington, WV, agreed. He said that blood sugar supplements are proving to be steady sellers for Tulsi, with the first few months of the year bringing in new customers interested in metabolic health.
Gut Microbiome Comes Into Focus
The gut microbiome is becoming a key focus for blood sugar supplements. Roza noted that the attention being paid to the gut-brain axis is a growing trend in blood sugar support, with this axis thought to influence everything from diabetes to weight loss to cognitive faculties. Germano explained that he has seen a growing interest in microbiome-focused formulas for blood sugar support, with new products incorporating probiotics like Akkermansia muciniphila and various strains of Bifidobacterium. These ingredients are growing in the blood sugar space because of their documented links to glucose regulation and gut barrier support.
“Natural GLP-1 pathway support is also surging, featuring berberine for AMPK activation, fibers like glucomannan for satiety, and multi-ingredient blends combining botanicals like cinnamon, Gymnema sylvestre and alpha-lipoic acid with chromium,” Germano continued. “Comprehensive products targeting multiple pathways, such as probiotic plus botanical plus fiber, are aligning with post-holiday resolutions and cardiometabolic prevention.”
Blood sugar, Germano said, now ranks as a top wellness category, which is happening while consumers demand research-backed claims and regulators take aim at this niche.
Fenaux noted that glucose management supplements aren’t just a trend; they’re a response to a global metabolic crisis. The future of this category, Fenaux said, will not belong to blood sugar support blends, but rather to mechanistically precise, clinically substantiated formulations that can combine multiple functions.
“This category will be dominated by products that support a healthy and balanced post-meal response,” Fenaux said. “Furthermore, top products will also support insulin sensitivity and metabolic function, reduce oxidative stress in the body, and integrate with muscle and microbiome health.”
At the same time, Fenaux said, credibility is becoming a defining differentiator. Brands that focus on clinical validation, transparency, and responsible positioning will become category leaders.
Michael Lane, scientific coordinator with Phynova, explained that beyond a trend toward more immediate interventions for blood sugar management, this space is also seeing increased research into the cascading benefits of healthy blood glucose.
“We’re seeing a lot of interest in the microbiome effects of fiber and prebiotics, and how this can help regulate appetite as well as affect the brain,” Lane said. “This trend is ongoing; healthy blood sugar is cementing itself as the cornerstone of good metabolic health.”
GLP-1 Agonist Drugs Raise Awareness
Blood sugar management options are growing for consumers, as GLP-1 drugs demonstrate strong efficacy, as well as effects on weight management. Supplement manufacturer Wakunaga of America Director of Sales Jay Levy in Mission Viejo, CA, noted that these drugs are reshaping how consumers, clinicians and brands think about blood sugar and metabolic health. There is now a rapid, industry-wide repositioning happening, with blood sugar-focused dietary supplements taking on the angle of supporting GLP-1s, providing for appetite control, and creating metabolic resilience.
Lane explained that while GLP-1s were originally developed for the management of type 2 diabetes, the term has since become synonymous with weight loss. The GLP-1 hormone, he said, plays an important role in stabilizing blood sugar by promoting glucose-stimulated insulin release. The hormone also has a further effect on the brain, stimulating feelings of satiety.
“As these therapies have grown in visibility, we’ve seen increased consumer interest in nutritional approaches that promote satiety, balanced energy intake, and healthy glucose metabolism,” Lane said. “Some ingredient research is exploring how certain nutrients interact with pathways involved in fullness and metabolic regulation. However, it’s important that supplements are positioned responsibly—that is, as supportive tools for overall metabolic health, not as substitutes for medical therapies.”
Manufacturers Take Validation, Safety Into Consideration
The manufacturers behind these blood sugar supplements are taking a robust approach to safety and efficacy. Levy noted that at Wakunaga, the company offers Kyolic Blood Pressure Health, a comprehensive supplement made from aged garlic extract and a unique combination of Salacia, bitter melon, niacin and chromium picolinate. These ingredients have been shown to support healthy blood sugar levels in studies.
Lynch, meanwhile, said that responsible formulation in metabolic health requires formulators to pay attention to human clinical validation, defined mechanisms of action, clinically relevant dosing, safety and tolerability concerns, and regulatory alignment. He cited the example of Ingredients by Nature’s branded Sytrinol, a patented blend of citrus polymethyloxylated flavones and tocotrienols. When manufacturers select ingredients with published human data, Lynch said, they support both retail education and long-term consumer confidence.
For Fenaux, manufacturers need to consider three key pillars when developing blood sugar support ingredients: Mechanism of action, evidence, and user experience. Healthy glucose metabolism is a multi-layered function, Fenaux explained, from carbohydrate digestion in the gut to cellular uptake in the muscle. The more sophisticated approach is to modulate glucose before it gets into the body, rather than trying to aggressively force changes downstream.
“Evidence and dosing are critical,” Fenaux said. “Serious brands look for human clinical data and aim to formulate at meaningful levels, especially when targeting post-meal glucose, which is increasingly recognized as a key driver of metabolic stress.”
Tolerability and positioning also matter, Fenaux noted. Products need to be easy to take before meals, gentle on the gut, and responsibly framed as supportive tools within a broader metabolic strategy.
Beyond safety and efficacy, there are other concerns that manufacturers are taking into consideration. Germano said that clean-label, non-GMO (genetically modified organism), and vegan are all key claims that support sales in the metabolic support arena.
Hornfeldt said that from a retailer’s perspective, the products that earn repeat customers are the ones that are thoughtfully formulated and clearly dosed. Customers in this category are often monitoring their lab work, she explained, so they want to know that what they’re taking is meaningful and not just pixie dusted.
“We appreciate when manufacturers provide education that helps us explain mechanisms in simple terms,” she added. “Quality control, third-party testing and standardized extracts are important because trust is everything in this category.”
Emerging Studies Prove Out Supplementation
Manufacturers and retailers are continually interested in high-quality clinical trials that demonstrate the safety and efficacy of blood sugar support and metabolic health supplements. Roza said that he’s primarily interested in studies associated with the microbiome. While the importance of the microbiome may seem like a new revelation, he noted that the concept of the microbiome as a key health influence goes all the way back to ancient Greece, with Hippocrates stating that “all disease begins in the gut”.
“This has led Layn to develop a unique polysaccharide that was first discovered in Tibetan topsoil called Galacan,” Roza noted. “Our preliminary investigations have shown how this ingredient not only positively impacts microbiome diversity, but also combats inflammation, improves the immune response, and promotes healthy aging. Currently, a 120-person double-blind human clinical study is underway to prove our hypothesis as to how Galacan can improve metabolic health.”
Lynch said that he’s currently most interested in research exploring the nutritional modulation of GLP-1 pathways, as well as areas of research into the gut-metabolic axis, low-grade inflammation as a driver of metabolic imbalance, polyphenols and insulin sensitivity, and cardiometabolic biomarkers.
“The industry is increasingly recognizing that metabolic dysfunction is multifactorial,” Lynch said. “Emerging research indicates that flavonoids can simultaneously influence oxidative stress, inflammatory cytokines and lipid metabolism.”
Andrew Gallagher, head of global science for Phynova, said the company has built a robust base of clinical evidence supporting the benefits related to maintaining healthy blood glucose and insulin levels. Phynova is currently investigating how maintaining healthy glucose metabolism impacts appetite, body composition, menopause, cognition, the microbiome and longevity.
“We’re aiming to understand how maintaining normal postprandial excursions shifts appetite and reward-driven eating,” Gallagher said. “We’re also interested in pragmatic free-living studies, including consumer live lab designs that capture continuous glucose monitor data, behavior and real-world dietary patterns.”
Meanwhile, Germano cited a recent clinical study proving that synergistic blends show promise for GLP-1 pathway support and prediabetes prevention. This study was an analysis of 10 trials on a total of 4,500 prediabetic subjects. The analysis found that 18.5 percent of vitamin D recipients normalized their blood sugar, compared to 14 percent in the placebo condition. This suggests that vitamin D has beta-cell support and insulin sensitivity benefits, and that these effects are more pronounced in deficient individuals.
Manufacturers Support Retail Sales
Fenaux said that manufacturers are now realizing that retail success in metabolic health isn’t just about shelf space; rather, it’s about education and clarity. As a result, leading brands are now investing in strong retailer training, simple clinical summaries, and clear mechanism explainers so retail staff can confidently communicate the benefits of various products.
“Manufacturers are also tailoring products to specific personas,” Fenaux noted. “They’re targeting CGM-driven biohackers, weight management consumers and midlife metabolic health seekers rather than just speaking generically about blood sugar.”
Germano, meanwhile, said that manufacturers are helping retailers move product through digital marketing and content marketing, influencers and community engagement, and retail-specific tactics like in-store demos and shelf talkers.
“The biggest support is education,” Hornfeldt said. “This is not a self-serve category. Customers have questions, and our staff needs clear, accurate talking points. Brands that provide staff trainings, concise research summaries, and easy-to-understand shelf materials really help us have better conversations. Promotions and sampling can help, but ultimately, this category grows through trust and education.”
Metabolic Health Supplements Get More Sophisticated
Metabolic health is no longer just a trend; it’s a long-term health priority for consumers. Fenaux noted that the long-term winners in this category won’t position themselves as pharmaceutical substitutes, but rather, as supportive tools within a broader metabolic wellness strategy combining nutrition, movement, muscle health and microbiome modulation.
“Healthy glucose metabolism is no longer a niche condition-specific concern,” Fenaux said. “It’s becoming a foundational pillar of metabolic balance. As consumer awareness grows, particularly through wearable tracking and lifestyle changes, we expect the category to move toward more integrated, evidence-aware solutions that support long-term metabolic resilience.”VR
For More Information:
Bluebonnet Nutrition, https://bluebonnetnutrition.com
Ingredients by Nature, https://ingredientsbynature.com
Layn, https://layncorp.com
Phynova, www.phynova.com
Wakunaga, https://kyolic.com


